- Headquarters
- Vancouver, Canada · North America
- Value chain
- Research & IP(Research & design); also Professional & data services
- What that means
- Invents and licenses: corporate and contract research, IP and technology licensing, with little production of its own.
- Founded
- 2012
- Ownership
- Listed
- Listing
- Nasdaq:ABCL on Google Finance
- Website
- abcellera.com
- Relevance
- Moderate at its strongest, in Advanced Therapeutics, Vaccines & Medical Countermeasures
In 1 capability
Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.
Biotechnology & Health Technologies · Research · listed #35 of 50
AI-enabled antibody discovery platform that found bamlanivimab, the first authorised COVID-19 monoclonal antibody, in about 90 days under the DARPA pandemic-prevention programme.
Relevance: AI antibody discovery platform